We are live on ! Find out more
LPC

Lion Point Capital Portfolio holdings

AUM $16.7M
1-Year Est. Return 119.35%
This Fund
S&P 500
This Quarter Est. Return
+7.13%
1 Year Est. Return
+119.35%
3 Year Est. Return
+204.43%
5 Year Est. Return
+220.32%
10 Year Est. Return
+1,396.08%
AUM
$454M
AUM Growth
-$425M
Cap. Flow
-$464M
Cap. Flow %
-102.31%
Top 10 Hldgs %
68.39%
Holding
48
New
8
Increased
7
Reduced
8
Closed
7

Top Buys

Rank Stock Value
1
MIST icon
Milestone Pharmaceuticals
MIST
+$4.62M
2
ERF
Enerplus Corporation
ERF
+$4.21M
3
CIVI
Civitas Resources
CIVI
+$3.83M
4
MIRM icon
Mirum Pharmaceuticals
MIRM
+$1.93M
5
CHRD icon
Chord Energy
CHRD
+$1.67M

Top Sells

Rank Stock Value
1
SWIR
Sierra Wireless
SWIR
+$31.9M
2
RNW icon
ReNew
RNW
+$10M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$8.88M
4
EXE
Expand Energy Corp
EXE
+$8.46M
5
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$6.86M

Sector Composition

Rank Sector Weight
1 Energy 21.1%
2 Healthcare 13.42%
3 Financials 5.85%
4 Consumer Discretionary 3.89%
5 Communication Services 3.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCRB icon
26
Seres Therapeutics
MCRB
$46.8M
$3.23M 0.71%
31,340
+7,250
+30% +$743K
BFIIW
27
CALL
DELISTED
BurgerFi International, Inc. Warrant
BFIIW
$3.2M 0.71%
2,083,438
– –
APTV icon
28
PUT
Aptiv
APTV
$12B
$3.13M 0.69%
40,000
– –
BWA icon
29
PUT
BorgWarner
BWA
$13.1B
$2.51M 0.55%
90,880
– –
MIRM icon
30
Mirum Pharmaceuticals
MIRM
$6.46B
$1.72M 0.38%
+80,000
New +$1.93M
BLU
31
DELISTED
BELLUS Health Inc.
BLU
$1.39M 0.31%
+150,000
New +$1.59M
ORGN
32
DELISTED
Origin Materials
ORGN
$1M 0.22%
3,333
– –
LUMO
33
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$732K 0.16%
51,205
– –
CBAY
34
DELISTED
Cymabay Therapeutics
CBAY
$704K 0.16%
+219,425
New +$788K
ARDX icon
35
Ardelyx
ARDX
$1.22B
$666K 0.15%
+550,000
New +$523K
SDIG
36
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
$380K 0.08%
2,000
– –
ISEE
37
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$284K 0.06%
29,541
-676,627
-96% -$8.88M
SCOR icon
38
Comscore
SCOR
$106M
$25K 0.01%
50
– –
MSFT icon
39
Microsoft
MSFT
$3.45T
$23K 0.01%
+100
New +$26.4K
SWIR
40
DELISTED
Sierra Wireless
SWIR
$3K ﹤0.01%
100
-1,110,571
-100% -$31.9M
ELVN icon
41
Enliven Therapeutics
ELVN
$3.92B
– –
-208,695
Closed -$1.14M
INVZ icon
42
Innoviz Technologies
INVZ
$95M
– –
-400,000
Closed -$4M
RNW icon
43
ReNew
RNW
$2.27B
– –
-1,000,000
Closed -$10M
SMH icon
44
PUT
VanEck Semiconductor ETF
SMH
$65.2B
– –
-1,700,000
Closed -$173M
SYRE icon
45
Spyre Therapeutics
SYRE
$8.54B
– –
-12,000
Closed -$1.43M
NTBL
46
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
– –
-74,094
Closed -$5.75M
SWIR
47
CALL
DELISTED
Sierra Wireless
SWIR
– –
-2,000,000
Closed -$46.8M
1
2

Similar funds

PA
PPM America Chicago, Illinois $16.6M AUM 31.99% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
SRA
Summit Rock Advisors New York $16M AUM
CP
Covalent Partners Concord, Massachusetts $17.6M AUM 2.91% 1-Year Est. Return
B
BP London, United Kingdom $17.7M AUM 12.34% 1-Year Est. Return
BCPE
Bain Capital Public Equity Boston, Massachusetts $18M AUM 35.19% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $18.1M AUM 29.08% 1-Year Est. Return

Lion Point Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Lion Point Capital held 48 positions worth $454M, down 48% from $878M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Lion Point Capital withdrew a net $464M in Q3 2022, closing 7 positions and reducing 8 holdings. Its most notable exit was ReNew, an estimated $10M position sold in full.

By sector, the portfolio is most concentrated in Energy at 21% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Lion Point Capital opened a new position in Mirum Pharmaceuticals worth $1.72M.

  • Lion Point Capital's largest Q3 2022 buy was Mirum Pharmaceuticals: 80,000 shares worth $1.72M.
  • Lion Point Capital added most to Milestone Pharmaceuticals in Q3 2022, an estimated $4.62M increase.
  • Lion Point Capital's biggest Q3 2022 reduction was Sierra Wireless, cutting an estimated $31.9M.
  • Lion Point Capital fully exited ReNew in Q3 2022, selling an estimated $10M.
  • Lion Point Capital's ten largest holdings make up 68% of its $454M portfolio in Q3 2022.
  • Lion Point Capital opened 8 new positions and closed 7 in Q3 2022.
  • Lion Point Capital's portfolio value fell 48% quarter-over-quarter to $454M.

Based on Lion Point Capital's 13F filing for Q3 2022, filed 14 Nov 2022.